Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease

Hypertension

Volumn 59, Issue 1, 2012, Pages 105-112

  Fujita, Megumi ^a   Ando, Katsuyuki ^a   Kawarazaki, Hiroo ^a   Kawarasaki, Chiaki ^a   Muraoka, Kazuhiko ^a   Ohtsu, Hiroshi ^a   Shimizu, Hideki ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

brain; chronic kidney disease; hypertension; oxidative stress; salt; sympathetic nervous system

Indexed keywords

HEXAMETHONIUM; LUCIGENIN; MOXONIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; SUPEROXIDE; TEMPOL; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BRAIN; BRAIN VENTRICLE; CHEMOLUMINESCENCE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GANGLION BLOCK; GLOMERULOSCLEROSIS; HEART RATE; HISTOPATHOLOGY; HYPERTENSION; HYPOTHALAMUS; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; SALT LOADING; SYMPATHETIC NERVE; SYMPATHETIC TONE; UNINEPHRECTOMY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; BRAIN; CYCLIC N-OXIDES; HEART RATE; HEXAMETHONIUM; HYPERTENSION, RENAL; INFUSIONS, INTRAVENTRICULAR; MALE; NEPHRECTOMY; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RENAL INSUFFICIENCY, CHRONIC; SODIUM CHLORIDE, DIETARY; SPIN LABELS; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM;

EID: 83655167069     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.182923     Document Type: Article

References (53)

1. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918. (Pubitemid 23006966)
2. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20:933-939.
3. Ishii M, Ikeda T, Takagi M, Sugimoto T, Atarashi K, Igari T, Uehara Y, Matsuoka H, Hirata Y, Kimura K, Takeda T, Murao S. Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension. 1983;5:545-551. (Pubitemid 13076694)
4. Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol. 2003;14:3239-3244. (Pubitemid 37509299)
5. Siddiqi L, Prakken NH, Velthuis BK, Cramer MJ, Oey PL, Boer P, Bots ML, Blankestijn PJ. Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment. Nephrol Dial Transplant. 2010;25:3272-3277.
6. Levitan D, Massry SG, Romoff M, Campese VM. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. Nephron. 1984;36: 24-29. (Pubitemid 14211339)
7. Krespi PG, Makris TK, Hatzizacharias AN, Triposkiadis P, Tsoukala C, Kyriaki D, Votteas V, Kyriakidis M. Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 levels in patients with essential hypertension. Cardiovasc Drugs Ther. 1998;12: 463-467. (Pubitemid 29002784)
8. DiBona GF, Sawin LL. Effect of renal denervation on dynamic autoregulation of renal blood flow. Am J Physiol Renal Physiol. 2004;286: F1209-F1218. (Pubitemid 38656378)
9. Sato Y, Ando K, Ogata E, Fujita T. High potassium intake attenuates antinatriuretic response to air stress in doca-salt rats. Am J Physiol. 1991;260:R941-R945.
10. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
11. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197. (Pubitemid 27069290)
12. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25: 878-882.
13. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979. (Pubitemid 35176304)
14. Ditting T, Tiegs G, Veelken R. Autonomous innervation in renal inflammatory disease-innocent bystander or active modulator? J Mol Med. 2009;87:865-870.
15. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension. 2003;42: 968-973. (Pubitemid 37413739)
16. Kopp UC, Smith LA, DiBona GF. Impaired renorenal reflexes in spontaneously hypertensive rats. Hypertension. 1987;9:69-75. (Pubitemid 17227143)
17. Fujita M, Kuwaki T, Ando K, Fujita T. Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension. 2005;45:1165-1172. (Pubitemid 40770322)
18. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension. 2007;50:360-367. (Pubitemid 47205786)
19. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation. 2009;119: 978-986.
20. Laffer CL, Bolterman RJ, Romero JC, Elijovich F. Effect of salt on isoprostanes in salt-sensitive essential hypertension. Hypertension. 2006; 47:434-440. (Pubitemid 43740287)
21. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30: 400-418.
22. Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal dahl salt-sensitive rats. Nephrol Dial Transplant. 2010;25:2879-2889.
23. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension. 2007; 50:877-883. (Pubitemid 350287529)
24. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep. 2002;4:160-166.
25. Campese VM, Karubian F. Salt sensitivity in hypertension: implications for the kidney. J Am Soc Nephrol. 1991;2:S53-S61.
26. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144: 21-28. (Pubitemid 46780716)
27. Ye S, Zhong H, Yanamadala S, Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension. 2006;48:309-315. (Pubitemid 44309828)
28. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR, Paton JF. Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension. 2010;56:290-296.
29. Carlstrom M, Sallstrom J, Skott O, Larsson E, Persson AE. Uninephrectomy in young age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension. 2007;49:1342-1350. (Pubitemid 46809378)
30. Kawarazaki H, Ando K, Fujita M, Matsui H, Nagae A, Muraoka K, Kawarasaki C, Fujita T. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats. Am J Physiol Renal Physiol. 2011;300:F1402-F1409.
31. Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol. 2000;11:1469-1478. (Pubitemid 30483463)
32. Sato Y, Ando K, Fujita T. Role of sympathetic nervous system in hypotensive action of taurine in doca-salt rats. Hypertension. 1987;9: 81-87. (Pubitemid 17227145)
33. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol. 2008;294: H1067-H1074. (Pubitemid 351253321)
34. Ono A, Kuwaki T, Kumada M, Fujita T. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension. 1997;29:808-814. (Pubitemid 27097989)
35. Lu N, Helwig BG, Fels RJ, Parimi S, Kenney MJ. Central tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central Ang II. Am J Physiol Heart Circ Physiol. 2004;287: H2626-H2633. (Pubitemid 39557133)
36. de Wardener HE. The hypothalamus and hypertension. Physiol Rev. 2001;81:1599-1658. (Pubitemid 32947779)
37. Matsui H, Ando K, Kawarazaki H, Nagae A, Fujita M, Shimosawa T, Nagase M, Fujita T. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension. 2008;52:287-294.
38. De Matteo R, Head GA, Mayorov DN. Tempol in the dorsomedial hypothalamus attenuates the hypertensive response to stress in rabbits. Am J Hypertens. 2006;19:396-402.
39. Mayorov DN, Head GA, De Matteo R. Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress. Hypertension. 2004;44:101-106. (Pubitemid 38823495)
40. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol. 2004;287:H695-H703. (Pubitemid 38955301)
41. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004;109:2357-2362. (Pubitemid 38656873)
42. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91:1038-1045. (Pubitemid 35416641)
43. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 2005; 46:533-539. (Pubitemid 41376834)
44. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004;95:210-216. (Pubitemid 38988688)
45. Nishimura M, Takahashi H, Yoshimura M. Upregulation of the brain renin-angiotensin system in rats with chronic renal failure. Acta Physiol (Oxf). 2007;189:369-377. (Pubitemid 46426925)
46. Huang BS, White RA, Jeng AY, Leenen FH. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in saltinduced hypertension in dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2009;296:R994-R1000.
47. Ito K, Hirooka Y, Sunagawa K. Blockade of mineralocorticoid receptors improves salt-induced left-ventricular systolic dysfunction through attenuation of enhanced sympathetic drive in mice with pressure overload. J Hypertens. 2010;28:1449-1458.
48. Rossi NF, Maliszewska-Scislo M, Chen H, Black SM, Sharma S, Ravikov R, Augustyniak RA. Neuronal nitric oxide synthase within paraventricular nucleus: Blood pressure and baroreflex in two-kidney, one-clip hypertensive rats. Exp Physiol. 2010;95:845-857.
49. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res. 2005;96:252-260. (Pubitemid 40209373)
50. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ, Harrison DG. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension. 2010;55:277-283, 6p following 283.
51. DiBona GF, Jones SY. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla. Hypertension. 2001;37:1114-1123. (Pubitemid 32304013)
52. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728. (Pubitemid 29501288)
53. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002; 105:1354-1359. (Pubitemid 34260428)